Manufactures surfactants — surface-active ingredients used in personal care products such as shampoos, soaps, baby care items, feminine hygiene, scalp care and anti-acne formulations. Sells a mix of Performance Surfactants (commodity-grade) and Specialty Surfactants (premium, differentiated), with India specialty volumes growing over 27% in FY26. Operates manufacturing facilities in India (Taloja and Jhagadia) and Egypt, and serves customers across India, AMET (Africa, Middle East and Turkey), Americas and Europe, with exports at 38.3% of sales across 68 countries. Recent launches include Galsoft Lumithic, an amino-acid-based mild surfactant, and specialty capex of INR480 crore has been deployed over three years. Raw materials dominate the cost structure at 73.6% of revenue — primarily oleochemicals such as fatty alcohols, plus petrochemical inputs like ethylene oxide and sulfur — and feedstock prices rose sharply through FY26. Per-tonne profitability was INR20,114 in Q4 FY26 versus INR21,715 a year earlier, reflecting feedstock inflation and supply-chain disruption from the West Asia conflict. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Performance Surfactants, Specialty Surfactants, India, AMET (Africa, Middle East, Turkey), Americas, Europe. Multi-region, asset-heavy specialty chemicals (surfactants) manufacturer exposed to feedstock price swings.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 3,686 | 4,445 | 3,794 | 4,224 | 5,248 |
| EBITDA (ex other income) | 401 | 568 | 462 | 484 | 463 |
| margin % | 10.9 | 12.8 | 12.2 | 11.5 | 8.8 |
| Owners' profit | 263 | 381 | 301 | 305 | 267 |
| EPS, as reported (₹) | 74.12 | 107.46 | 85.03 | 86.00 | 75.41 |
| ROE % · ROCE % | 16.7 · 19.7 | 20.2 · 24.1 | 13.8 · 17.2 | 12.9 · 16.1 | 9.7 · 12.7 |
| Debt / equity (x) | 0.23 | 0.14 | 0.06 | 0.06 | 0.06 |
| Cash from operations | 5 | 573 | 518 | 421 | 333 |
| Capex | (155) | (146) | (158) | (219) | (137) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,063 | 1,042 | 1,145 | 1,278 | 1,326 | 1,329 | 1,315 | 1,782 |
| Profit before tax | 104 | 77 | 100 | 99 | 79 | 73 | 80 | 207 |
| Net profit | 85 | 65 | 76 | 79 | 66 | 59 | 62 | 166 |
| EPS (₹) | 23.90 | 18.22 | 21.40 | 22.42 | 18.75 | 16.63 | 17.60 | 46.80 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| PIDILITE INDUSTRIES LTD | 1,59,479 | 60.2 | 14.43 | 42.3 | 22.4 | 28.0 | 14.9 | 28.6 |
| SRF LTD | 73,583 | 34.0 | 5.24 | 22.7 | 13.1 | 13.1 | 13.4 | 25.2 |
| GUJARAT FLUOROCHEM LTD | 52,514 | 85.7 | 6.64 | 41.5 | 7.3 | 8.7 | 13.5 | 27.7 |
| NAVIN FLUORINE INT. LTD | 43,836 | 55.4 | 11.03 | 39.5 | 16.7 | 16.4 | 23.0 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 3 Sept 2026 · Galaxy Surfactants to meet analysts and investors on Sep 8 and 10 | general | low | — | — |
| 3 Sept 2026 · Galaxy Surfactants to hold analyst and investor meetings in Mumbai on Sep 8 and 10 | board shareholder meetings | low | — | — |
| 27 Aug 2026 · Galaxy Surfactants to attend Elara Capital investor meet on Sept 2 | board shareholder meetings | low | — | — |
| 20 Aug 2026 · Galaxy Surfactants Q1 FY27 transcript, record EBITDA of INR 252.5 crore | investor communications | medium | — | — |
| 19 Aug 2026 · Galaxy Surfactants signs Partnership Growth Charter with Unilever | strategic transactions | high | — | — |
| 13 Aug 2026 · Galaxy Surfactants Q1 FY27 results: Revenue up 39% YoY, PAT more than doubles | results | high | — | — |
| 12 Aug 2026 · 40th AGM concluded; final dividend of Rs 22 per share approved | board shareholder meetings | medium | — | — |
| 10 Aug 2026 · Galaxy Surfactants Q1FY27 earnings call on Aug 14 | board shareholder meetings | low | — | — |
| 6 Aug 2026 · Board meeting on Aug 13 to consider Q1 FY27 results | results | low | — | — |
| 22 Jul 2026 · Galaxy Surfactants grants 8,400 stock options to employees under PSOP 2025 | capital market events | medium | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| 37.5 |
| AETHER INDUSTRIES LIMITED | 22,229 | 94.3 | 9.05 | 60.4 | 8.9 | 11.4 | — | 33.8 |
| DEEPAK NITRITE LTD | 21,769 | 27.8 | 3.71 | 22.4 | 9.4 | 10.2 | 12.6 | 21.5 |
| ATUL LTD | 18,401 | 23.1 | 2.92 | 14.9 | 10.9 | 13.3 | 10.9 | 23.1 |
| AARTI INDUSTRIES LTD | 17,846 | 33.6 | 3.00 | 18.8 | 7.0 | 4.4 | 13.0 | 16.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 21.9 | 23.4 | 48 of 103 | 54% |
| P/B | 2.8 | 2.9 | 48 of 99 | 52% |
| ROCE | 11.6 | 10.3 | 48 of 108 | 56% |
| ROE | 9.7 | 8.1 | 45 of 101 | 56% |
| Debt / Equity | 0.1 | 0.2 | 39 of 101 | 62% |
| EBITDA margin | 14.2 | 15.5 | 55 of 99 | 45% |
| Revenue growth | 39.4 | 24.4 | 24 of 94 | 75% |
| Profit growth | 108.7 | 55.1 | 25 of 92 | 74% |
| Market cap | 7760 | 732 | 19 of 107 | 83% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
